Electra Therapeutics, Inc. (ETRA) Balance Sheet
ETRA balance sheet, 2025
December 31, 2025 · U.S. dollars$99.4M assets = $129.7M liabilities + −$30.3M equity
Liabilities exceed assets: shareholders’ equity is negative (−$30.3M).
Both columns are drawn to the same scale: what ETRA owns equals what it owes plus shareholders’ equity. Hover a block for its value.
ETRA financial health
Descriptive bands, not a rating. Fiscal 2025.
ETRA balance sheet trends, 2024–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $19.4M2024 | $99.4M2025 | +411.7%/yr | |
| Total liabilities | $122.7M2024 | $129.7M2025 | +5.7%/yr | |
| Shareholders’ equity | −$103.3M2024 | −$30.3M2025 | — | |
| Cash & short-term investments | $15.8M2024 | $86.5M2025 | +448.1%/yr | |
| Working capital | $15.2M2024 | $85.8M2025 | +$70.5M | |
| Book value per share | −$1.652024 | −$0.482025 | — | |
| Current ratio | 4.632024 | 9.822025 | +5.19 | |
| Shares outstanding | 62.8M2024 | 62.8M2025 | 0.0%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
ETRA assets
ETRA liabilities and equity
ETRA debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
ETRA balance sheet
| 2025 | 2024 | |
|---|---|---|
| Assets | ||
| Cash & short-term investments | $86.5M | $15.8M |
| Cash & equivalents | $33.0M | $14.8M |
| Short-term investments | $53.5M | $998,000 |
| Receivables | $0 | $0 |
| Inventory | $0 | $0 |
| Other current assets | $9.0M | $3.6M |
| Total current assets | $95.5M | $19.4M |
| Property, plant & equipment (net) | $2.8M | $0 |
| Goodwill & intangible assets | $0 | $0 |
| Long-term investments | $0 | $0 |
| Other non-current assets | $1.1M | $0 |
| Total assets | $99.4M | $19.4M |
| Liabilities | ||
| Accounts payable | $4.1M | $1.5M |
| Total current liabilities | $9.7M | $4.2M |
| Long-term debt | $0 | $0 |
| Lease obligations | $2.1M | $0 |
| Other long-term liabilities | $120.0M | $118.5M |
| Total liabilities | $129.7M | $122.7M |
| Shareholders' equity | ||
| Retained earnings (deficit) | −$173.0M | −$111.0M |
| Total shareholders' equity | −$30.3M | −$103.3M |
| Key figures | ||
| Working capital | $85.8M | $15.2M |
| Tangible book value | −$30.3M | −$103.3M |
| Book value per share | −$0.48 | −$1.65 |
| Shares outstanding | 62.8M | 62.8M |
| Current ratio | 9.82 | 4.63 |
| Quick ratio | 8.90 | 3.76 |
| Equity / assets | −30.5% | −531.7% |
| Jun '26 | Dec '25 | |
|---|---|---|
| Assets | ||
| Cash & short-term investments | $97.7M | $86.5M |
| Cash & equivalents | $66.5M | $33.0M |
| Short-term investments | $31.2M | $53.5M |
| Receivables | $0 | $0 |
| Inventory | $0 | $0 |
| Other current assets | $2.6M | $9.0M |
| Total current assets | $100.4M | $95.5M |
| Property, plant & equipment (net) | $2.4M | $2.8M |
| Goodwill & intangible assets | $0 | $0 |
| Long-term investments | $0 | $0 |
| Other non-current assets | $3.7M | $1.1M |
| Total assets | $106.5M | $99.4M |
| Liabilities | ||
| Accounts payable | $4.6M | $4.1M |
| Total current liabilities | $13.6M | $9.7M |
| Long-term debt | $0 | $0 |
| Lease obligations | $2.0M | $2.1M |
| Other long-term liabilities | $119.6M | $120.0M |
| Total liabilities | $133.3M | $129.7M |
| Shareholders' equity | ||
| Retained earnings (deficit) | −$221.9M | −$173.0M |
| Total shareholders' equity | −$26.8M | −$30.3M |
| Key figures | ||
| Working capital | $86.7M | $85.8M |
| Tangible book value | −$26.8M | −$30.3M |
| Book value per share | −$0.43 | −$0.48 |
| Shares outstanding | 62.8M | 62.8M |
| Current ratio | 7.37 | 9.82 |
| Quick ratio | 7.17 | 8.90 |
| Equity / assets | −25.1% | −30.5% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed —); data from EODHD.
ETRA financial position
At the end of fiscal 2025 (December 31, 2025), Electra Therapeutics had total assets of $99.4 million (up 411.7% from a year earlier), total liabilities of $129.7 million and shareholders' equity of -$30.3 million. Its current ratio was 9.82. In the latest quarter (ended June 30, 2026) total assets were $106.5 million and equity -$26.8 million.
Related: ETRA income statement, ETRA cash flow statement, ETRA key metrics. See the ETRA stock overview for the latest quote and news.
ETRA balance sheet FAQ
What are Electra Therapeutics's total assets?
Electra Therapeutics reported total assets of $99.4 million at the end of fiscal 2025 (December 31, 2025), compared with $19.4 million a year earlier.
How much cash does Electra Therapeutics have?
Electra Therapeutics held $86.5 million in cash and short-term investments at the end of fiscal 2025.
What is Electra Therapeutics's book value?
Electra Therapeutics's shareholders' equity (book value) was -$30.3 million at the end of fiscal 2025, or −$0.48 per share.
What is Electra Therapeutics's current ratio?
Electra Therapeutics had current assets of $95.5 million and current liabilities of $9.7 million, a current ratio of 9.82 (it can cover its short-term obligations).